Covered recipient · General Payments record
FAHAD ALAM
This page merges CMS profile IDs 7229876, 7233210 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2019–2024
$789.72
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $122.36 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $31.63 | 2 |
| Alexion Pharmaceuticals, Inc. | $25.96 | 1 |
| ABBVIE INC. | $21.04 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.03 | 1 |
| Ascensia Diabetes Care US Inc. | $15.59 | 1 |
| Abbott Laboratories | $10.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $10.11 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140290410 | CMS |
| ABBVIE INC. | $21.04 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103195680 | CMS |
| Alexion Pharmaceuticals, Inc. | $25.96 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093943933 | CMS |
| Ascensia Diabetes Care Us Inc. | $15.59 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089089570 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.03 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086166118 | CMS |
| Novo Nordisk Inc | $15.16 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096841011 | CMS |
| Novo Nordisk Inc | $16.47 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096740596 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs
- 7229876, 7233210
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.